Concurrent Offering of Common Stock. Concurrently with this offering, pursuant to a separate prospectus supplement, the Issuer priced an underwritten public offering of 60,240,000 shares (69,276,000 shares if the underwriters exercise their over-allotment option with respect to that offering in full) of the Issuer’s common stock (the “Common Stock Offering”). Neither the completion of the Common Stock Offering nor the completion of this offering is contingent on the completion of the other. Assuming no exercise of the underwriters’ over-allotment option with respect to the Common Stock Offering, the net proceeds of the Common Stock Offering, after deducting the underwriting discount and estimated expenses, will be approximately $239.7 million, based on a public offering price of $4.15 per share.
Concurrent Offering of Common Stock. On June 4, 2009, we priced a separate public offering of 10,000,000 shares of Common Stock (11,500,000 if the underwriters exercise their over-allotment option in full) (the “Equity Offering”). Assuming no exercise of the underwriters’ over-allotment option, the net proceeds of the Equity Offering will be $138.3 million, after deducting the underwriting discount and estimated expenses of the Equity Offering payable by us. As of March 31, 2009, after giving effect to the Notes Offering and the Equity Offering and the application of the estimated proceeds therefrom, we had $216.8 million of borrowings outstanding under our bank credit facility. The closing of the Notes Offering is not conditioned upon the completion of the Equity Offering.
Concurrent Offering of Common Stock. The Company is offering concurrently with this Series A Preferred Stock offering an issue of the Company’s common stock, $.01 par value per share. The size of the common stock offering is 9,500,000 shares (excluding the underwriters’ option to purchase up to 1,425,000 additional shares of common stock) at an offer price of $13.25. Additional details of the common stock offering, including a review of risk factors, are available on the SEC website at xxx.xxx.xxx.
Concurrent Offering of Common Stock. Concurrently with this offering of Convertible Notes, pursuant to a separate prospectus supplement, we are offering [ ] shares ([ ] shares if the underwriters exercise their over-allotment option with respect to that offering in full) of our common stock in an underwritten public offering (the “Common Stock Offering”). Neither the completion of the Common Stock Offering nor the completion of this offering is contingent on the completion of the other. Assuming no exercise of the underwriters’ over-allotment option with respect to the Common Stock Offering, the net proceeds of the Common Stock Offering, after deducting the underwriting discount and estimated expenses, will be approximately $[ ] million. 1 To be conformed to the Description of Notes in Prospectus. We have filed a registration statement (including a preliminary prospectus supplement) with the SEC for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement included in that registration statement and other documents we have filed with the SEC for more complete information about us and this offering. You may get these documents for free by visiting XXXXX on the SEC website at xxx.xxx.xxx. Alternatively, we or the underwriters will arrange to send you the prospectus if you request it by calling toll-free 1-877-858-5407. Schedule IV Persons signing Lock-Up Agreements Xxxxx Xxxxx Xxxxxxx Xxxxxxxxxxx Xxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxx Xxxxxxxxx
Concurrent Offering of Common Stock. The disclosure in the Preliminary Prospectus Supplement under the heading “Summary—Recent Developments—Concurrent Common Stock Offering” is modified to read as follows: Concurrently with this offering, pursuant to a separate prospectus supplement, we are offering 22,000,000 shares of our common stock in an underwritten public offering (or 25,300,000 shares if the underwriters for that offering fully exercise their option to purchase additional shares). Assuming no exercise of the underwriters’ option to purchase additional shares with respect to the common stock offering, we estimate that the net proceeds of the common stock offering, after deducting the underwriting discount and estimated expenses, will be approximately $60.1 million (or $69.2 million if the underwriters for that offering fully exercise their option to purchase additional shares), although there can be no assurance that the common stock offering will be completed. Completion of this offering is not contingent on the completion of the common stock offering, and the completion of the common stock offering is not contingent on the completion of this offering.
Concurrent Offering of Common Stock. Concurrently with the Offering, the Issuer is offering 11,250,000 shares of its common stock (or 12,937,500 shares if the underwriters exercise their option to purchase additional shares in full) pursuant to a separate prospectus supplement (the “Common Stock Offering”). The completion of the Offering is not contingent upon the closing of the Common Stock Offering, and the Common Stock Offering is not contingent upon the closing of the Offering. In addition, neither the Offering nor the Common Stock Offering is or will be contingent on the consummation of the Acquisition or any additional debt financing.
